{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T12:41:49Z","timestamp":1763988109208,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["175083"],"award-info":[{"award-number":["175083"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s11845-020-02395-0","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T02:03:10Z","timestamp":1602727390000},"page":"1137-1142","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Longitudinal study of neuropathic pain in patients with Guillain-Barr\u00e9 syndrome"],"prefix":"10.1007","volume":"190","author":[{"given":"Zoran","family":"Vukojevic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Berisavac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivo","family":"Bozovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Dominovic-Kovacevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dragana","family":"Lavrnic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2979-556X","authenticated-orcid":false,"given":"Stojan","family":"Peric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,15]]},"reference":[{"key":"2395_CR1","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","volume":"29","author":"JJ Sejvar","year":"2011","unstructured":"Sejvar JJ, Kohl KS, Gidudu J et al (2011) Guillain-Barr\u00e9 syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 29:599\u2013612","journal-title":"Vaccine"},{"key":"2395_CR2","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1212\/WNL.0b013e3181f88345","volume":"75","author":"L Ruts","year":"2010","unstructured":"Ruts L, Drenthen J, Longen JLM et al (2010) Pain in Guillain-Barre\u00b4 syndrome. A long-term follow-up study. Neurology 75:1439\u20131447","journal-title":"Neurology"},{"issue":"2","key":"2395_CR3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1212\/WNL.48.2.328","volume":"48","author":"DE Moulin","year":"1997","unstructured":"Moulin DE, Hagen N, Feasby TE et al (1997) Pain in Guillain-Barr\u00e9 syndrome. Neurology. 48(2):328\u2013331","journal-title":"Neurology."},{"issue":"6","key":"2395_CR4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s004150170157","volume":"248","author":"RA Bernsen","year":"2001","unstructured":"Bernsen RA, Jager AE, Schmitz PI, van der Mech\u00e9 FG (2001) Long-term sensory deficit after Guillain-Barr\u00e9 syndrome. J Neurol 248(6):483\u2013486","journal-title":"J Neurol"},{"key":"2395_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jns.2004.09.021","volume":"227","author":"A Forsberg","year":"2004","unstructured":"Forsberg A, Press R, Einarsson U et al (2004) Impairment in Guillain-Barr\u00e9 syndrome during the first 2 years after onset: a prospective study. J Neurol Sci 227:131\u2013138","journal-title":"J Neurol Sci"},{"issue":"10","key":"2395_CR6","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1007\/s00415-006-0515-2","volume":"254","author":"L Ruts","year":"2007","unstructured":"Ruts L, van Koningsveld R, Jacobs BC, van Doorn PA (2007) Determination of pain and response to methylprednisolone in Guillain-Barr\u00e9 syndrome. J Neurol 254(10):1318\u20131322","journal-title":"J Neurol"},{"key":"2395_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.36076\/ppj.2018.2.111","volume":"21","author":"AK Artemiadis","year":"2018","unstructured":"Artemiadis AK, Panagiotis Z (2018) Neuropathic pain in acute and subacute neuropathies: a systematic review. Pain Physician 21:111\u2013120","journal-title":"Pain Physician"},{"key":"2395_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.pain.2010.05.017","volume":"151","author":"V Martinez","year":"2010","unstructured":"Martinez V, Fletcher D, Martin F et al (2010) Small fibre impairment predicts neuropathic pain in Guillain-Barr\u00e9 syndrome. Pain 151:53\u201360","journal-title":"Pain"},{"issue":"2","key":"2395_CR9","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ncl.2013.01.005","volume":"31","author":"MM Dimachkie","year":"2013","unstructured":"Dimachkie MM, Barohn RJ (2013) Guillain-Barr\u00e9 syndrome and variants. Neurol Clin 31(2):491\u2013510","journal-title":"Neurol Clin"},{"key":"2395_CR10","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","volume":"2","author":"RA Hughes","year":"1978","unstructured":"Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM (1978) Controlled trial prednisolone in acute polyneuropathy. Lancet 2:750\u2013753","journal-title":"Lancet"},{"issue":"8","key":"2395_CR11","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1097\/j.pain.0000000000000492","volume":"157","author":"NB Finnerup","year":"2016","unstructured":"Finnerup NB, Haroutounian S, Kamerman P et al (2016) Neuropathic pain: an updated grading system for research and clinical practice. Pain 157(8):1599\u20131606","journal-title":"Pain"},{"issue":"5","key":"2395_CR12","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/S1474-4422(18)30071-1","volume":"17","author":"N Attal","year":"2018","unstructured":"Attal N, Bouhassira D, Baron R (2018) Diagnosis and assessment of neuropathic pain through questionnaires. Lancet Neurol 17(5):456\u2013466","journal-title":"Lancet Neurol"},{"key":"2395_CR13","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1185\/030079906X132488","volume":"22","author":"R Freynhagen","year":"2006","unstructured":"Freynhagen R, Baron R, Gockel U, Tolle TR (2006) painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 22:1911\u20131920","journal-title":"Curr Med Res Opin"},{"key":"2395_CR14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.pain.2011.10.037","volume":"153","author":"L Ruts","year":"2012","unstructured":"Ruts L, van Doorn PA, Lombardi R et al (2012) Unmyelinated and myelinated skin nerve damage in Guillain\u2013Barr\u00e9 syndrome: correlation with pain and recovery. Pain 153:399\u2013409","journal-title":"Pain"},{"issue":"6","key":"2395_CR15","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1097\/00000539-200212000-00046","volume":"95","author":"CK Pandey","year":"2002","unstructured":"Pandey CK, Bose N, Garg G et al (2002) Gabapentin for the treatment of pain in Guillain-Barr\u00e9 syndrome: a double-blinded, placebo-controlled, crossover study. Anesth Analg 95(6):1719\u20131723","journal-title":"Anesth Analg"},{"key":"2395_CR16","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1213\/01.ANE.0000152186.89020.36","volume":"101","author":"CK Pandey","year":"2005","unstructured":"Pandey CK, Raza M, Tripathi M et al (2005) The comparative evaluation of gabapentin and carbamazepine for pain management in Guillain-Barre\u00b4 syndrome patients in the intensive care unit. Anesth Analg 101:220\u2013225","journal-title":"Anesth Analg"},{"issue":"3","key":"2395_CR17","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/00003246-200003000-00009","volume":"28","author":"M Tripathi","year":"2000","unstructured":"Tripathi M, Kaushik S (2000) Carbamezapine for pain management in Guillain-Barr\u00e9 syndrome patients in the intensive care unit. Crit Care Med 28(3):655\u2013658","journal-title":"Crit Care Med"},{"issue":"9","key":"2395_CR18","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1007\/s004150070122","volume":"247","author":"M Koga","year":"2000","unstructured":"Koga M, Yuki N, Hirata K (2000) Pain in Miller Fisher syndrome. J Neurol 247(9):720\u2013721","journal-title":"J Neurol"},{"issue":"5","key":"2395_CR19","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1212\/WNL.49.5.1474","volume":"49","author":"A Khatri","year":"1997","unstructured":"Khatri A, Pearlstein L (1997) Pain in Guillain-Barr\u00e9 syndrome. Neurology 49(5):1474\u2013141474. https:\/\/doi.org\/10.1212\/WNL.49.5.1474","journal-title":"Neurology"},{"key":"2395_CR20","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/mus.1228","volume":"25","author":"M Sanchez-Guerra","year":"2002","unstructured":"Sanchez-Guerra M, Infante J, Pascual J, Berciano J (2002) Severe backache in Guillain-Barre\u00b4 syndrome. Muscle Nerve 25:468","journal-title":"Muscle Nerve"},{"issue":"8\u20139","key":"2395_CR21","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S0035-3787(04)71037-1","volume":"160","author":"R Kabore","year":"2004","unstructured":"Kabore R, Magy L, Boukhris S et al (2004) Contribution of corticosteroid to the treatment of pain in the acute phase of Guillain-Barr\u00e9 syndrome. Rev Neurol (Paris) 160(8\u20139):821\u2013823","journal-title":"Rev Neurol (Paris)"},{"key":"2395_CR22","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/jnnp.62.6.637","volume":"62","author":"RA Bernsen","year":"1997","unstructured":"Bernsen RA, Jacobs HM, de Jager AE, van der Meche FG (1997) Residual health status after Guillain-Barre\u00b4 syndrome. J Neurol Neurosurg Psychiatry 62:637\u2013640","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2395_CR23","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1212\/WNL.53.2.409","volume":"53","author":"RA Bernsen","year":"1999","unstructured":"Bernsen RA, de Jager AE, Schmitz PI et al (1999) Residual physical outcome and daily living 3 to 6 years after Guillain-Barre\u00b4 syndrome. Neurology 53:409\u2013410","journal-title":"Neurology"},{"key":"2395_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0022-510X(02)00158-2","volume":"201","author":"RA Bernsen","year":"2002","unstructured":"Bernsen RA, de Jager AE, Schmitz PI et al (2002) Long-term impact on work and private life after Guillain-Barre\u00b4 syndrome. J Neurol Sci 201:13\u201317","journal-title":"J Neurol Sci"},{"key":"2395_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1600-0404.2005.00429.x","volume":"112","author":"RA Bernsen","year":"2005","unstructured":"Bernsen RA, de Jager AE, van der Mech\u00e9 FG et al (2005) How Guillain-Barre\u00b4 patients experience their functioning after one year. Acta Neurol Scand 112:51\u201356","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"2395_CR26","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.disamonth.2010.02.008","volume":"56","author":"KR Mullings","year":"2010","unstructured":"Mullings KR, Alleva JT, Hudgkins TH (2010) Rehabilitation of GuillainBarr\u00e9 syndrome. Dis Mon 56(5):288\u2013292","journal-title":"Dis Mon"},{"issue":"7","key":"2395_CR27","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1136\/jnnp-2011-301882","volume":"83","author":"YA Rajabally","year":"2012","unstructured":"Rajabally YA, Uncini A (2012) Outcome and its predictors in Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 83(7):711\u2013718","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2395_CR28","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1017\/cjn.2018.12","volume":"45","author":"V Martic","year":"2018","unstructured":"Martic V, Bozovic I, Berisavac I et al (2018) Three-year follow-up study in patients with Guillain-Barr\u00e9 syndrome. Can J Neurol Sci 45:269\u2013274","journal-title":"Can J Neurol Sci"},{"issue":"34","key":"2395_CR29","doi-asserted-by":"publisher","first-page":"e11595","DOI":"10.1097\/MD.0000000000011595","volume":"97","author":"S Yao","year":"2018","unstructured":"Yao S, Chen H, Zhang Q et al (2018) Pain during the acute phase of Guillain\u2013Barr\u00e9 syndrome. Medicine (Baltimore) 97(34):e11595. Published online 2018 Aug 24. https:\/\/doi.org\/10.1097\/MD.0000000000011595","journal-title":"Medicine (Baltimore)"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-020-02395-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-020-02395-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-020-02395-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T04:29:15Z","timestamp":1634272155000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-020-02395-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,15]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["2395"],"URL":"https:\/\/doi.org\/10.1007\/s11845-020-02395-0","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"type":"print","value":"0021-1265"},{"type":"electronic","value":"1863-4362"}],"subject":[],"published":{"date-parts":[[2020,10,15]]},"assertion":[{"value":"9 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethical Board of the Neurology Clinic, Clinical Center of Serbia. The manuscript complies with the Declaration of Helsinki and all other relevant national and inernational laws regarding the involvement of human subjects. All patients signed informed consent to participate in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}